Uppsala, Sweden
Professor of Vascular Surgery
Uppsala University
Consultant Vascular Surgery
Uppsala University Hospital
SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Presenter
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, REPORTING STANDARDS AND CLASSIFICATION SYSTEMS, STABILISE, GUIDELINES AND MORE
Multicenter International Study Shows That There Is A Role For Endovascular Treatment Of Complex Aortic Diseases From Marfans, Loeys-Dietz And Ehlers-Danlos Syndromes: What Is This Role
10:02 AM - 10:07 AM
Wednesday, November 20, 2024
Presenter
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
DEBATE: There Is High Level Evidence That Men With AAAs <5.5 cm Should NOT Undergo Elective Repair: AAAs < 6 cm In Men Rarely Rupture: The Thresholds For Repair Of Aortic And Iliac Aneurysms Need To Be Raised
2:00 PM - 2:05 PM
Thursday, November 21, 2024
Presenter
SESSION 52: MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAS, COMPLEX AAAS AND TAAAS; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
In Situ Laser Fenestration For Endovascular Treatment Of Complex Ruptured AAAs: What Equipment Is Needed: When Is It Feasible And Why Is It Better Than Other Treatments: Technical Tips
2:06 PM - 2:11 PM
Presenter
SESSION 52: MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAS, COMPLEX AAAS AND TAAAS; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
The Future Of AAA Screening: The Changing Epidemiology Especially Persistent Declining Prevalence Mandates Changes In Screening Recommendations
3:12 PM - 3:17 PM
Friday, November 22, 2024
Presenter
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
Optimal Techniques In 2024 For Treating Infected Aortoiliac Prosthetic Grafts And Endografts (Including EVAR, TEVAR, F/B/EVAR): From A Large National Cohort And The GRANDPA Global Registry
8:26 AM - 8:31 AM
 
previous next